Reata Pharma (RETA) Tops Q3 EPS by 89c; Reports Cash and Cash Equivalents of $713.2M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Reata Pharma (RETA) Tops Q3 EPS by 89c; Reports Cash and Cash Equivalents of $713.2M

Reata Pharma (RETA) Files Mixed Shelf Registration Statement

November 8, 2021 7:17 AM EST

Reata Pharma (NASDAQ: RETA) files mixed shelf registration statement of:

CLASS A COMMON STOCK

CLASS B COMMON STOCK

PREFERRED STOCK

WARRANTS

DEPOSITARY SHARES

STOCK PURCHASE CONTRACTS

STOCK PURCHASE UNITS

RIGHTS

... More